However, changes in liver PDFF in the dapagliflozin group were correlated with changes in the SCD-1 index (16:1 n-7/16:0), which mostly reflects hepatic fatty acid metabolism [24] and is associated with liver fat content [24], NAFLD [37] and lobular inflammation [38]. The gene discussed is SCD; the disease is metabolic dysfunction-associated steatotic liver disease.